J. Martin HEROLD

Follow

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of tyrosine kinase 2 mediated signaling
- Patent number 10,508,113
- Issue date Dec 17, 2019
- AbbVie Inc.
- Maria A. Argiriadi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic kinase inhibitors
- Patent number 10,280,184
- Issue date May 7, 2019
- AbbVie Inc.
- Michael M. Friedman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Primary carboxamides as BTK inhibitors
- Patent number 9,567,339
- Issue date Feb 14, 2017
- AbbVie Inc.
- Dominique Bonafoux
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING
- Publication number 20190276450
- Publication date Sep 12, 2019
- ABBVIE INC.
- Maria A. Argiriadi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC KINASE INHIBITORS
- Publication number 20190135836
- Publication date May 9, 2019
- ABBVIE INC.
- Michael Friedman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRIMARY CARBOXAMIDES AS BTK INHIBITORS
- Publication number 20170174624
- Publication date Jun 22, 2017
- ABBVIE INC.
- Dominique Bonafoux
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC KINASE INHIBITORS
- Publication number 20170114077
- Publication date Apr 27, 2017
- ABBVIE INC.
- Michael M. FRIDEMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRIMARY CARBOXAMIDES AS BTK INHIBITORS
- Publication number 20150005279
- Publication date Jan 1, 2015
- ABBVIE INC.
- Dominique Bonafoux
- C07 - ORGANIC CHEMISTRY